KR970001343A - 나프탈렌 유도체,그의 제조 방법,및그의 중간체 - Google Patents
나프탈렌 유도체,그의 제조 방법,및그의 중간체Info
- Publication number
- KR970001343A KR970001343A KR1019960021677A KR19960021677A KR970001343A KR 970001343 A KR970001343 A KR 970001343A KR 1019960021677 A KR1019960021677 A KR 1019960021677A KR 19960021677 A KR19960021677 A KR 19960021677A KR 970001343 A KR970001343 A KR 970001343A
- Authority
- KR
- South Korea
- Prior art keywords
- intermediates
- preparing
- methods
- naphthalene derivatives
- naphthalene
- Prior art date
Links
- 239000000543 intermediate Substances 0.000 title 1
- 150000002790 naphthalenes Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
- C07F7/1804—Compounds having Si-O-C linkages
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Pulmonology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyridine Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP95-149288 | 1995-06-15 | ||
JP14928895 | 1995-06-15 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR970001343A true KR970001343A (ko) | 1997-01-24 |
KR100435247B1 KR100435247B1 (ko) | 2004-09-10 |
Family
ID=15471914
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019960021677A KR100435247B1 (ko) | 1995-06-15 | 1996-06-15 | 나프탈렌유도체,그의제조방법,및그의중간체 |
Country Status (21)
Country | Link |
---|---|
US (3) | US6005106A (ko) |
EP (1) | EP0748805B1 (ko) |
KR (1) | KR100435247B1 (ko) |
CN (1) | CN1063748C (ko) |
AR (1) | AR002483A1 (ko) |
AT (1) | ATE164843T1 (ko) |
AU (1) | AU706156B2 (ko) |
BG (1) | BG62521B1 (ko) |
BR (1) | BR9602802A (ko) |
CA (1) | CA2178974C (ko) |
DE (1) | DE69600221T2 (ko) |
ES (1) | ES2116131T3 (ko) |
HK (1) | HK1010116A1 (ko) |
HU (1) | HU222340B1 (ko) |
IL (1) | IL118469A (ko) |
MY (1) | MY121606A (ko) |
NO (1) | NO310109B1 (ko) |
RU (1) | RU2129120C1 (ko) |
SG (1) | SG47152A1 (ko) |
TW (1) | TW349098B (ko) |
ZA (1) | ZA964652B (ko) |
Families Citing this family (39)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ID19155A (id) * | 1996-12-13 | 1998-06-18 | Tanabe Seiyaku Co | Turunan-turunan piridin, pembuatannya dan intermediet untuk pembuatannya |
JPH1171351A (ja) * | 1997-08-29 | 1999-03-16 | Ss Pharmaceut Co Ltd | 置換キノロン誘導体及びこれを含有する医薬 |
ATE261483T1 (de) | 1998-05-05 | 2004-03-15 | Massachusetts Inst Technology | Lichtemittierende polymere und vorrichtungen, die diese enthalten |
US20050147534A1 (en) | 1998-05-05 | 2005-07-07 | Massachusetts Institute Of Technology | Emissive sensors and devices incorporating these sensors |
NZ517166A (en) | 1999-08-21 | 2004-01-30 | Altana Pharma Ag | Synergistic combination of PDE inhibitors and beta 2 adrenoceptor agonists |
MXPA03010672A (es) * | 2001-05-23 | 2004-03-02 | Tanabe Seiyaku Co | Composicion para el tratamiento regenerativo de enfermedades del cartilago. |
EP1389468A4 (en) * | 2001-05-23 | 2007-01-10 | Tanabe Seiyaku Co | COMPOSITIONS PROMOTING THE GUISON OF A BONE FRACTURE |
TWI221838B (en) | 2001-08-09 | 2004-10-11 | Tanabe Seiyaku Co | Pyrazinoisoquinoline compound or naphthalene compound |
WO2003049702A2 (en) * | 2001-12-10 | 2003-06-19 | Amgen Inc. | Vanilloid receptor ligands and their use in treatments |
WO2003057689A1 (en) * | 2002-01-02 | 2003-07-17 | Fujisawa Pharmaceutical Co., Ltd. | Aminopyrimidine compounds, processes for their preparation and pharmaceutical compositions containing them |
AU2003247425B2 (en) * | 2002-05-22 | 2007-03-08 | Amgen Inc. | Amino-pyridine, -pyridine and pyridazine derivatives for use as vanilloid receptor ligands for the treatment of pain |
BR0313255A (pt) * | 2002-08-08 | 2005-07-12 | Amgen Inc | Composto, composição farmacêutica, uso de um composto e métodos de fabricar um medicamento e de preparar um composto |
EP1604981A4 (en) | 2003-03-14 | 2008-12-24 | Ono Pharmaceutical Co | NITROGENIC HETEROCYCLIC DERIVATIVES AND MEDICAMENTS CONTAINING THEM AS AN ACTIVE SUBSTANCE |
AU2004226353A1 (en) | 2003-04-01 | 2004-10-14 | Laboratoires Serono Sa | Inhibitors of phosphodiesterases in infertility |
CA2525843A1 (en) * | 2003-05-16 | 2004-12-02 | University Of Chicago | Optical fractionation methods and apparatus |
AU2004278382B2 (en) * | 2003-09-30 | 2008-09-18 | Amgen Inc. | Vanilloid receptor ligands and their use in treatments |
WO2005077938A1 (en) * | 2004-02-11 | 2005-08-25 | Amgen Inc. | Vanilloid receptor ligands and their use in treatments |
MY139645A (en) * | 2004-02-11 | 2009-10-30 | Amgen Inc | Vanilloid receptor ligands and their use in treatments |
RU2409565C2 (ru) | 2004-09-13 | 2011-01-20 | Оно Фармасьютикал Ко., Лтд. | Азотистые гетероциклические производные и лекарственные средства, содержащие их в качестве активного ингредиента |
US8617819B2 (en) | 2004-09-17 | 2013-12-31 | Massachusetts Institute Of Technology | Polymers for analyte detection |
TWI339578B (en) * | 2004-10-29 | 2011-04-01 | Mitsubishi Tanabe Pharma Corp | Use of a pyridine compound for the preparation of a medicament for the treatment of skin lesions |
US7301022B2 (en) * | 2005-02-15 | 2007-11-27 | Amgen Inc. | Vanilloid receptor ligands and their use in treatments |
US20060235036A1 (en) * | 2005-04-15 | 2006-10-19 | Doherty Elizabeth M | Vanilloid receptor ligands and their use in treatments |
EP1964925B1 (en) * | 2005-10-04 | 2016-03-30 | Mitsubishi Tanabe Pharma Corporation | Process for production of optically active 4-hydroxy-1,2,3,4 -tetrahydroquinolines |
EP1944291B1 (en) | 2005-10-04 | 2012-06-13 | Mitsubishi Tanabe Pharma Corporation | Optically active cyclic alcohol compound and method for producing same |
AU2006300478B2 (en) * | 2005-10-05 | 2010-06-17 | Mitsubishi Tanabe Pharma Corporation | Dermatitis treating agent |
BRPI0708731A2 (pt) | 2006-03-10 | 2011-06-07 | Ono Pharmaceutical Co | derivado heterocìclico nitrogenado, e agente farmacêutico compreendendo o derivado como ingrediente ativo |
WO2007112347A1 (en) * | 2006-03-28 | 2007-10-04 | Takeda Pharmaceutical Company Limited | Dipeptidyl peptidase inhibitors |
WO2008042289A2 (en) | 2006-09-29 | 2008-04-10 | Massachusetts Institute Of Technology | Polymer synthetic technique |
US8802447B2 (en) | 2006-10-05 | 2014-08-12 | Massachusetts Institute Of Technology | Emissive compositions with internal standard and related techniques |
US20090215189A1 (en) | 2006-10-27 | 2009-08-27 | Massachusetts Institute Of Technology | Sensor of species including toxins and chemical warfare agents |
US20080207659A1 (en) * | 2007-02-15 | 2008-08-28 | Asit Kumar Chakraborti | Inhibitors of phosphodiesterase type 4 |
US20100215579A1 (en) * | 2007-04-10 | 2010-08-26 | The Trustees Of The University Of Pennsylvania | Phen-naphthalene and phen-quinoline derivatives and their use for binding and imaging amyloid plaques |
US9125807B2 (en) | 2007-07-09 | 2015-09-08 | Incept Llc | Adhesive hydrogels for ophthalmic drug delivery |
US20140121240A1 (en) * | 2011-06-28 | 2014-05-01 | Maruho Co., Ltd. | Novel pharmaceutical composition |
JPWO2013027835A1 (ja) | 2011-08-25 | 2015-03-19 | 田辺三菱製薬株式会社 | 光学活性ナフタレン化合物の製法 |
US11970440B1 (en) | 2023-10-30 | 2024-04-30 | King Faisal University | 8-(3-chlorobenzylideneamino)naphthalene-1,3-disulfonic acid as an antioxidant compound |
US11932593B1 (en) | 2023-10-31 | 2024-03-19 | King Faisal University | 8-(3-bromobenzylideneamino)naphthalene-1,3-disulfonic acid as an antioxidant compound |
US11987543B1 (en) | 2023-10-31 | 2024-05-21 | King Faisal University | 8-(4-bromobenzylideneamino)naphthalene-1,3-disulfonic acid as an antioxidant compound |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3042156B2 (ja) * | 1992-02-20 | 2000-05-15 | 田辺製薬株式会社 | ナフタレン誘導体、その製法及びその合成中間体 |
US5342841A (en) * | 1992-03-12 | 1994-08-30 | Kyowa Hakko Kogyo Co., Ltd. | Xanthine derivatives |
EP0731084B1 (de) * | 1995-03-03 | 2002-09-25 | Rolic AG | Photovernetzbare Naphthylderivate |
-
1996
- 1996-05-30 IL IL11846996A patent/IL118469A/xx not_active IP Right Cessation
- 1996-05-31 TW TW085106502A patent/TW349098B/zh not_active IP Right Cessation
- 1996-06-03 MY MYPI96002135A patent/MY121606A/en unknown
- 1996-06-04 ES ES96304033T patent/ES2116131T3/es not_active Expired - Lifetime
- 1996-06-04 EP EP96304033A patent/EP0748805B1/en not_active Expired - Lifetime
- 1996-06-04 DE DE69600221T patent/DE69600221T2/de not_active Expired - Lifetime
- 1996-06-04 AT AT96304033T patent/ATE164843T1/de active
- 1996-06-04 AU AU54693/96A patent/AU706156B2/en not_active Expired
- 1996-06-11 SG SG1996010041A patent/SG47152A1/en unknown
- 1996-06-12 BG BG100656A patent/BG62521B1/bg unknown
- 1996-06-14 HU HU9601652A patent/HU222340B1/hu active IP Right Grant
- 1996-06-14 AR ARP960103158A patent/AR002483A1/es not_active Application Discontinuation
- 1996-06-14 US US08/663,991 patent/US6005106A/en not_active Expired - Lifetime
- 1996-06-14 CA CA002178974A patent/CA2178974C/en not_active Expired - Lifetime
- 1996-06-14 NO NO962527A patent/NO310109B1/no not_active IP Right Cessation
- 1996-06-14 BR BRPI9602802-5A patent/BR9602802A/pt not_active IP Right Cessation
- 1996-06-14 RU RU96112130A patent/RU2129120C1/ru active
- 1996-06-15 KR KR1019960021677A patent/KR100435247B1/ko active IP Right Grant
- 1996-06-15 ZA ZA964652A patent/ZA964652B/xx unknown
- 1996-06-17 CN CN96106608A patent/CN1063748C/zh not_active Expired - Lifetime
-
1998
- 1998-07-02 US US09/109,099 patent/US5969140A/en not_active Expired - Lifetime
- 1998-09-24 HK HK98110940A patent/HK1010116A1/xx not_active IP Right Cessation
- 1998-12-01 US US09/201,820 patent/US6214996B1/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
ZA964652B (en) | 1996-12-12 |
AU706156B2 (en) | 1999-06-10 |
CN1142497A (zh) | 1997-02-12 |
HK1010116A1 (en) | 1999-06-11 |
IL118469A (en) | 2000-08-13 |
BG62521B1 (bg) | 2000-01-31 |
DE69600221T2 (de) | 1998-08-06 |
KR100435247B1 (ko) | 2004-09-10 |
RU2129120C1 (ru) | 1999-04-20 |
US6005106A (en) | 1999-12-21 |
EP0748805A1 (en) | 1996-12-18 |
AU5469396A (en) | 1997-01-02 |
CA2178974C (en) | 2006-06-06 |
ES2116131T3 (es) | 1998-07-01 |
DE69600221D1 (de) | 1998-05-14 |
TW349098B (en) | 1999-01-01 |
HU9601652D0 (en) | 1996-08-28 |
US5969140A (en) | 1999-10-19 |
SG47152A1 (en) | 1998-03-20 |
NO962527D0 (no) | 1996-06-14 |
MY121606A (en) | 2006-02-28 |
BG100656A (en) | 1997-09-30 |
ATE164843T1 (de) | 1998-04-15 |
BR9602802A (pt) | 1998-10-06 |
EP0748805B1 (en) | 1998-04-08 |
AR002483A1 (es) | 1998-03-25 |
CN1063748C (zh) | 2001-03-28 |
US6214996B1 (en) | 2001-04-10 |
HUP9601652A1 (en) | 1997-09-29 |
NO310109B1 (no) | 2001-05-21 |
NO962527L (no) | 1996-12-16 |
HU222340B1 (hu) | 2003-06-28 |
IL118469A0 (en) | 1996-09-12 |
CA2178974A1 (en) | 1996-12-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR970001343A (ko) | 나프탈렌 유도체,그의 제조 방법,및그의 중간체 | |
DK0729951T3 (da) | Naphthylforbindelser, mellemprodukter, præparater og fremgangsmåder | |
NO980720D0 (no) | Pyridazin-3-on-derivater, deres anvendelse og mellomprodukter for deres fremstilling | |
IS1916B (is) | Estrógen gerandefni/mótefni, notkun þeirra og milliefni til framleiðslu þeirra | |
DK1036794T3 (da) | 2-Aryl-8-oxodihydropurinderivater, fremgangsmåde til fremstilling af samme, medicinske præparater indeholdende samme og mellemprodukter deraf | |
NO963015L (no) | Tetracykliske derivater, fremgangsmåte for fremstilling og anvendelse | |
EE03482B1 (et) | Kinasoliiniderivaadid, nende valmistamismeetod ja kasutamine | |
CY2013003I1 (el) | Φωσφονοκεφεμικα παραγωγα, διαδικασια για την παρασκευη τους, και χρηση αυτων | |
FI950715A0 (fi) | Ytmikromekanisk, symmetrisk tryckskillnadsgivare | |
KR970001365A (ko) | 알킬하이드로겐클로로실란의 제조방법 | |
DK0922050T3 (da) | 3-Descladinose-2,3-anhydroerythromycin-derivater | |
NO960499L (no) | Antineurodegenerativt virksomme 10-aminoalifatyldibenz[b,fÅoksepiner | |
ZA9610278B (en) | Pyridylcarbamates, processes and intermediates for their preparation, and their use. | |
DK0874814T3 (da) | 25-hydroxy-16-en-26,27-bishomo-cholecalciferoler | |
EE04117B1 (et) | Karboksüasendatud tsüklilised karboksamiidi derivaadid, nende valmistamise meetod ja kasutamine | |
DK0907633T3 (da) | Nye syntetiske catecholderivater, fremgangsmåde til fremstilling og anvendelse deraf | |
NO990411D0 (no) | Katalysator, anvendelse derav, og fremgangsmÕte for fremstilling derav | |
DE69712425D1 (de) | Naphthalin-Derivate, Zwischenprodukte und Verwendungen | |
NO960796D0 (no) | Benzotiofenonforbindelser, mellomprodukter, sammensetninger og fremgangsmåter | |
BR9508669A (pt) | Novos derivados de taizoloÚ3,2-a¾quinolina e naftirina | |
KR970001328A (ko) | 치환된 퀴놀린 제초제 중간체 및 이의 제조 방법 | |
FI952912A0 (fi) | Traedcylinder, gripelement med traedrotsprincip | |
ES1029889Y (es) | Baliza aerostatica perfeccionada. | |
FI950956A0 (fi) | Luftkabel, saosom haengspiralkabel | |
FI952416A0 (fi) | Distributionsanordning foer vaetska, speciellt tvaettvaetska foer vindrutor |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20130524 Year of fee payment: 10 |
|
FPAY | Annual fee payment |
Payment date: 20140530 Year of fee payment: 11 |
|
FPAY | Annual fee payment |
Payment date: 20150430 Year of fee payment: 12 |